[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100595055":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":15,"locations":20,"responsibleParty":74,"collaborators":76,"id":80,"slug":81,"hasResults":82,"nctId":83,"briefTitle":84,"officialTitle":85,"acronym":86,"eligibilityCriteria":87,"healthyVolunteers":82,"sex":88,"minAge":89,"maxAge":7,"enrollmentInfo":90,"targetDuration":93,"studyType":94,"phases":7,"briefSummary":95,"conditions":96,"keywords":101,"overallStatus":23,"whyStopped":7,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":108,"startDateStruct":111,"completionDateStruct":113,"leadSponsor":115,"locationsCount":116},{"fullName":5,"class":6},"Hospital Israelita Albert Einstein","OTHER",null,[9,12],{"name":10,"affiliation":5,"role":11},"Henrique A Fonseca, MD, PhD","STUDY_CHAIR",{"name":13,"affiliation":5,"role":14},"Anna M Gomes, MD","PRINCIPAL_INVESTIGATOR",[16],{"name":13,"role":17,"phone":18,"phoneExt":7,"email":19},"CONTACT","+55 11 2151-1233","anna.gomes@einstein.br",[21,42,59],{"facility":22,"status":23,"city":24,"state":25,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"Hospital São Vicente de Paulo","RECRUITING","Passo Fundo","Rio Grande do Sul","99010-080","Brazil","BR",{"type":30,"coordinates":31},"Point",[32,33],-52.40667,-28.26278,{"lat":33,"lon":32},[36,40],{"name":37,"role":17,"phone":38,"phoneExt":7,"email":39},"Aloma S Menegasso, Clinical Research Coordinator","+5554992216669","farmaloma@hsvp.com.br",{"name":41,"role":14,"phone":7,"phoneExt":7,"email":7},"Alexandre P Tognon, MD, PhD",{"facility":43,"status":23,"city":44,"state":45,"zip":46,"country":27,"countryCode":28,"cosmosGeoPoint":47,"geoPoint":51,"contacts":52},"Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - USP","Ribeirão Preto","São Paulo","14051-140",{"type":30,"coordinates":48},[49,50],-47.81028,-21.1775,{"lat":50,"lon":49},[53,57],{"name":54,"role":17,"phone":55,"phoneExt":7,"email":56},"Silvia F B M Negrini, Clinical Research Coordinator","+5516981349907","sissinegrini@gmail.com",{"name":58,"role":14,"phone":7,"phoneExt":7,"email":7},"Rodrigo C Santana, MD, PhD",{"facility":60,"status":23,"city":45,"state":45,"zip":61,"country":27,"countryCode":28,"cosmosGeoPoint":62,"geoPoint":66,"contacts":67},"Hospital Santa Marcelina","08270-070",{"type":30,"coordinates":63},[64,65],-46.63611,-23.5475,{"lat":65,"lon":64},[68,72],{"name":69,"role":17,"phone":70,"phoneExt":7,"email":71},"Carlos E Opazo, Clinical Research Coordinator","+5511985986136","carlos.opazocpc@santamarcelina.org",{"name":73,"role":14,"phone":7,"phoneExt":7,"email":7},"Vanessa L da Costa, MD",{"type":75,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[77],{"name":78,"class":79},"Ministry of Health, Brazil","OTHER_GOV","100595055","acute-treatment-and-long-term-assessment-of-adult-infectious-meningitis-100595055",false,"NCT07027475","Acute Treatment and Long-term Assessment of Adult Infectious Meningitis","Prospective Clinical Registry of Acute Treatment and Long-term Assessment of Adults Meningitis","ATLAS-I","Inclusion Criteria:\n\n* Fever (axillary temperature ≥37.8°C) followed by two or more of the following symptoms: severe headache, vomiting, altered consciousness (confusion, drowsiness, or irritability), photophobia (increased sensitivity to light), presence of seizures OR\n* Fever accompanied by at least one meningeal irritation sign, such as neck stiffness, Kernig's sign, or Brudzinski's sign OR\n* Sudden onset of fever and appearance of petechial skin rash or hemorrhagic suffusions\n\nExclusion Criteria:\n\n\\- Refusal to provide consent for study participation","ALL","18 Years",{"count":91,"type":92},624,"ESTIMATED","6 Months","OBSERVATIONAL","Prospective, multicenter, observational clinical registry of adult patients with acute infectious meningitis across approximately 30 public and private hospitals in Brazil. The study will include adults, 18 years old and older, with suspected acute infectious meningitis. Data will be collected during hospitalization and post-discharge to evaluate clinical management, treatment and short and long-term outcomes. The study aims to generate real-world evidence on current practices and outcomes to support improvements in national care protocols.",[97,98,99,100],"Viral Meningitis","Bacterial Meningitis","Fungal Meningitis","Meningitis",[100,102,103,104,105,106],"Bacterial","Viral","Corticosteroids","Antibiotics","Fungal","2026-05-04",{"date":109,"type":110},"2026-05-07","ACTUAL",{"date":112,"type":110},"2026-03-30",{"date":114,"type":92},"2027-02",{"name":5,"class":6},3]